Epitinib succinate

• Description :

  Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  548.59

• Molecular Formula :

  C28H32N6O6

• Notes :

  Research use only, not for human use.

• Receptor :

  Lysosomal acid lipase

• CAS Number :

  2252334-12-4